APTEKA-DI, OOO, Tatarstan, Republic

Accounting reports

Previously








Share:
Name
APTEKA-DI, OOO
INN
1646015589
KPP
164601001
OGRN
1041642600119
OKPO
70897629
Address
423603, Respublika Tatarstan (Tatarstan), Elabuga, pr-kt. Neftyanikov, d. 12, pomesch. 1000
Phone
2-76-99

Extract from EGRUL $12 (€10)

Last name, first name & patronymic of the General Director

List of founders

Position of the company

Licenses

Authorized capital

Branches

Complete structure of the extract
We guarantee to provide you with an actual
information extract

Data on types of economic activities
APTEKA-DI, OOO according to EGRUL

OKVED codeTypeName of activity type
47.73Core activity Retailing drugs in specialized stores (pharmacies)
46.46.1Additional activityWholesale of furniture, carpets and lighting equipment
46.46.2Additional activityWholesale of medical and orthopedic goods, dental and laboratory supplies
All types of activities
47.74Additional activity Retailing products used for medical purposes, orthopedic goods in specialized stores
47.75Additional activity Retailing of cosmetics and personal hygiene products in specialized stores
47.75.2Additional activityRetail drugstore products
Registration date
12.01.2004
Registering department
Mezhrayonnaya inspektsiya MNS Rossii N9 po Respublike Tatarstan

APTEKA-DI, OOO (Tatarstan, Republic; INN 1646015589) was registered on 12 Jan 2004. The company's authorized capital as of July 1, 2012 was 11000 rub.

Type of ownership of APTEKA-DI, OOO - Limited liability companies.

Form of ownership of APTEKA-DI, OOO - Private property.

Principal activities of APTEKA-DI, OOO: retailing drugs in specialized stores (pharmacies) (47.73), wholesale of furniture, carpets and lighting equipment (46.46.1), wholesale of medical and orthopedic goods, dental and laboratory supplies (46.46.2).

Economic indicators

2023

Net profit (RAS) of APTEKA-DI, OOO dropped in 2023 by 19.82% to 3.50 million RUB from 4.37 million RUB over the same period in 2022, the company informed.

Revenue remained in the accounting period at the same level and made up 78.46 million RUB compared to 78.63 million RUB 78.63 million RUB; cost of goods sold decreased by 0.63% to 60.65 million RUB from 61.03 million RUB; sales profit fell by 17.90% to 3.82 million RUB from 4.65 million RUB.

2022

Net profit (RAS) of APTEKA-DI, OOO grew over 2022 by 24.64% to 4.37 million RUB from 3.51 million RUB over 2021, the company informed.

Revenue increased in the accounting period by 10.20% to 78.63 million RUB from 71.35 million RUB over 2021; cost of goods sold grew by 10.29% to 61.03 million RUB from 55.34 million RUB; sales profit went up by 16.29% to 4.65 million RUB from 4.00 million RUB.

2021

Net profit (RAS) of APTEKA-DI, OOO dropped in 2021 by 23.83% to 3.51 million RUB from 4.60 million RUB over the same period in 2020, the company informed.

Revenue increased in the accounting period by 4.72% to 71.35 million RUB from 68.14 million RUB over 2020; cost of goods sold grew by 4.70% to 55.34 million RUB from 52.85 million RUB; sales profit fell by 15.41% to 4.00 million RUB from 4.73 million RUB.

2020

Net profit (RAS) of APTEKA-DI, OOO grew over 2020 1.75 times to 4.60 million RUB from 2.63 million RUB over 2019, the company informed.

Revenue increased in the accounting period by 24.68% to 68.14 million RUB from 54.65 million RUB over 2019; cost of goods sold grew by 27.37% to 52.85 million RUB from 41.50 million RUB; sales profit went up 1.70 times to 4.73 million RUB from 2.78 million RUB.

2019

Net profit (RAS) of APTEKA-DI, OOO grew over 2019 by 41.05% to 2.63 million RUB from 1.87 million RUB over 2018, the company informed.

Revenue increased in the accounting period by 9.11% to 54.65 million RUB from 50.09 million RUB over 2018; cost of goods sold grew by 10.12% to 41.50 million RUB from 37.68 million RUB; sales profit went up by 38.78% to 2.78 million RUB from 2.00 million RUB.

2018

Net profit (RAS) of APTEKA-DI, OOO made up 1.87 million RUB over 2018 compared to net loss of 1.22 million RUB over 2017, the company informed.

Revenue decreased in the accounting period by 3.00% to 50.09 million RUB from 51.64 million RUB in 2017; cost of goods sold decreased by 5.12% to 37.68 million RUB from 39.71 million RUB; sales profit fell by 28.25% to 2.00 million RUB from 2.79 million RUB.

2017

Net loss (RA) of APTEKA-DI, OOO made up 1.22 million RUB over 2017 compared to net profit of 3.70 million RUB over 2016, the company informed.

Revenue decreased in the accounting period by 2.85% to 51.64 million RUB from 53.15 million RUB in 2016; cost of goods sold decreased by 3.89% to 39.71 million RUB from 41.32 million RUB; sales profit fell by 20.04% to 2.79 million RUB from 3.49 million RUB.

2016

Net profit (RAS) of APTEKA-DI, OOO dropped in 2016 by 18.33% to 3.70 million RUB from 4.53 million RUB over the same period in 2015, the company informed.

Revenue remained in the accounting period at the same level and made up 53.15 million RUB compared to 53.41 million RUB 53.41 million RUB; cost of goods sold remained at the same level amounting to 41.32 million RUB compared to 41.45 million RUB; sales profit fell by 19.48% to 3.49 million RUB from 4.33 million RUB.

2014

Net profit (RAS) of Apteka-DI, OOO dropped in 2014 by 16.05% to 3.36 million RUB from 4.00 million RUB over the same period in 2013, the company informed.

Revenue increased in the accounting period by 5.24% to 48.31 million RUB from 45.90 million RUB over 2013; cost of goods sold grew by 5.20% to 37.40 million RUB from 35.55 million RUB; sales profit fell by 18.80% to 3.33 million RUB from 4.10 million RUB.

2013

Net profit (RAS) of Apteka-DI, OOO grew over 2013 1.67 times to 4.00 million RUB from 2.40 million RUB over 2012, the company informed.

Revenue increased in the accounting period by 9.47% to 45.90 million RUB from 41.93 million RUB over 2012; cost of goods sold grew by 6.63% to 35.55 million RUB from 33.34 million RUB; sales profit went up 1.61 times to 4.10 million RUB from 2.55 million RUB.

2012

Net profit (RAS) of Apteka-DI, OOO grew over 2012 2.19 times to 2.40 million RUB from 1.10 million RUB over 2011, the company informed.

Revenue increased in the accounting period by 5.73% to 41.93 million RUB from 39.66 million RUB over 2011; cost of goods sold grew by 2.63% to 39.38 million RUB from 38.37 million RUB.




Daily subscription $39 (€32)

unlimited access to database "Kontragent"

download any information within 24 hours

Companies in the region

Guarantees

Guarantees
We guarantee
provision of
relevant
information

Payment methods


Statistics
Companies
12 245 880
Reports
17 430 774
Rrocessed requests
Extract from EGRUL:
Today, 3:33 PM
Accounting reports:
Today, 3:32 PM
The site can contain materials of 16+ category
+7(495) 729−17−96,    info@k-agent.ru
Рейтинг@Mail.ru © "Info-RL", 2006—2024
About the project    Legal basis
Business Business Services Others Info-RL, ООО
Moscow ul. Kazakova, d. 3, str. 4 105064
+7(495) 729−17−96 7 days a week info@k-agent.ru